137 related articles for article (PubMed ID: 19487543)
21. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
[TBL] [Abstract][Full Text] [Related]
22. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
[TBL] [Abstract][Full Text] [Related]
23. [Mass spectrometric proteomic analysis of serum samples--a promising method for early diagnosis of cancer].
Jørgensen PE; Jensen ON; Hørder M
Ugeskr Laeger; 2002 Dec; 165(1):54-5. PubMed ID: 12529953
[No Abstract] [Full Text] [Related]
24. Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid.
Li J; Zhao J; Yu X; Lange J; Kuerer H; Krishnamurthy S; Schilling E; Khan SA; Sukumar S; Chan DW
Clin Cancer Res; 2005 Dec; 11(23):8312-20. PubMed ID: 16322290
[TBL] [Abstract][Full Text] [Related]
25. Biomarker discovery for ovarian cancer using SELDI-TOF-MS.
Zhang H; Kong B; Qu X; Jia L; Deng B; Yang Q
Gynecol Oncol; 2006 Jul; 102(1):61-6. PubMed ID: 16403569
[TBL] [Abstract][Full Text] [Related]
26. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.
Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P
Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929
[TBL] [Abstract][Full Text] [Related]
27. A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection.
Yasui Y; Pepe M; Thompson ML; Adam BL; Wright GL; Qu Y; Potter JD; Winget M; Thornquist M; Feng Z
Biostatistics; 2003 Jul; 4(3):449-63. PubMed ID: 12925511
[TBL] [Abstract][Full Text] [Related]
28. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
Geng X; Wang F; Li YG; Zhu GP; Zhang WM
J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
[TBL] [Abstract][Full Text] [Related]
29. Serum biomarkers for detection of breast cancers: A prospective study.
Mathelin C; Cromer A; Wendling C; Tomasetto C; Rio MC
Breast Cancer Res Treat; 2006 Mar; 96(1):83-90. PubMed ID: 16322896
[TBL] [Abstract][Full Text] [Related]
30. Proteomic profiling of ovine serum by SELDI-TOF MS: optimisation, reproducibility and feasibility of biomarker discovery using routinely collected samples.
Zhong L; Taylor DL; Whittington RJ
Comp Immunol Microbiol Infect Dis; 2010 Jan; 33(1):47-63. PubMed ID: 18775566
[TBL] [Abstract][Full Text] [Related]
31. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis.
Wei YS; Zheng YH; Liang WB; Zhang JZ; Yang ZH; Lv ML; Jia J; Zhang L
Cancer; 2008 Feb; 112(3):544-51. PubMed ID: 18085639
[TBL] [Abstract][Full Text] [Related]
32. Proteomic profile in familial breast cancer patients.
Garrisi VM; Tommasi S; Facchiano A; Bongarzone I; De Bortoli M; Cremona M; Cafagna V; Abbate I; Tufaro A; Quaranta M; Paradiso A
Clin Biochem; 2013 Feb; 46(3):259-65. PubMed ID: 23159292
[TBL] [Abstract][Full Text] [Related]
33. [Proteomic analysis of prostate cancer using surface enhanced laser desorption/ionization mass spectrometry].
Pan YZ; Xiao XY; Zhao D; Zhang L; Ji GY; Li Y; He DC; Zhao XJ; Yang BX
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3172-5. PubMed ID: 16405834
[TBL] [Abstract][Full Text] [Related]
34. SELDI-TOF serum proteomics and colorectal cancer: a current overview.
Gemoll T; Roblick UJ; Auer G; Jörnvall H; Habermann JK
Arch Physiol Biochem; 2010; 116(4-5):188-96. PubMed ID: 20615064
[TBL] [Abstract][Full Text] [Related]
35. Use of serological proteomic methods to find biomarkers associated with breast cancer.
Rui Z; Jian-Guo J; Yuan-Peng T; Hai P; Bing-Gen R
Proteomics; 2003 Apr; 3(4):433-9. PubMed ID: 12687611
[TBL] [Abstract][Full Text] [Related]
36. Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer.
Kong F; Nicole White C; Xiao X; Feng Y; Xu C; He D; Zhang Z; Yu Y
Gynecol Oncol; 2006 Feb; 100(2):247-53. PubMed ID: 16229881
[TBL] [Abstract][Full Text] [Related]
37. Case-control breast cancer study of MALDI-TOF proteomic mass spectrometry data on serum samples.
van der Werff MP; Mertens B; de Noo ME; Bladergroen MR; Dalebout HC; Tollenaar RA; Deelder AM
Stat Appl Genet Mol Biol; 2008; 7(2):Article2. PubMed ID: 18241195
[TBL] [Abstract][Full Text] [Related]
38. Time course proteomic profiling of human myocardial infarction plasma samples: an approach to new biomarker discovery.
Silbiger VN; Luchessi AD; Hirata RD; Neto LG; Pastorelli CP; Ueda EK; dos Santos ES; Pereira MP; Ramos R; Sampaio MF; Armaganijan D; Paik SH; Murata Y; Ooi GT; Ferguson EW; Hirata MH
Clin Chim Acta; 2011 May; 412(11-12):1086-93. PubMed ID: 21356205
[TBL] [Abstract][Full Text] [Related]
39. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y
J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
[TBL] [Abstract][Full Text] [Related]
40. Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry.
Hu S; Yu T; Xie Y; Yang Y; Li Y; Zhou X; Tsung S; Loo RR; Loo JR; Wong DT
Cancer Genomics Proteomics; 2007; 4(2):55-64. PubMed ID: 17804867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]